Table 2.
Summary data of bioequivalence (BE) analysis, via standard BE population ratio method, following noncompartmental pharmacokinetic analysis of Isoniazid and Rifampin in Native (N) and Co‐encapsulated (CoE) formulations of Rifamate using tools within FDA‐recognized Phoenix WinNonlin software (Certera)
| Isoniazid | Rifampin | |||
|---|---|---|---|---|
| Cmax | AUC | Cmax | AUC | |
| Bioequivalence confidence level | 95.00 | 95.00 | 95.00 | 95.00 |
| Ratio N/CoE | 94.547746 | 97.194316 | 82.072826 | 90.668841 |
| Ratio test | Bioequivalence shown | Bioequivalence shown | Bioequivalence shown | Bioequivalence shown |